8.1.5 Gefäße / Herz / Blut

Publikationen

1.

Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model.

Microvasc Res. 2011 Nov;82(3):263-8.
PMID: 21864545 [PubMed - indexed for MEDLINE]

2.

3-Acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity.

J Pharm Pharmacol. 2010 Feb;62(2):273-8.
PMID: 20487208 [PubMed - indexed for MEDLINE]

3.

BHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosis.

Recent Pat Inflamm Allergy Drug Discov. 2009 Jan;3(1):49-57.
PMID: 19149746 [PubMed - indexed for MEDLINE]

4.

Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration.

J Leukoc Biol. 2008 Jul;84(1):215-23.
PMID: 18436581 [PubMed - indexed for MEDLINE]

5.

Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice.

Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):272-7.
PMID: 18032778 [PubMed - indexed for MEDLINE]

6.

Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia.

Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):653-60.
PMID: 16677108 [PubMed - indexed for MEDLINE]

7.

Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells.

DNA Cell Biol. 2005 Apr;24(4):244-55.
PMID: 15812241 [PubMed - indexed for MEDLINE]

8.

Anti-inflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis.

Inflammopharmacology. 2004;12(2):131-52.
PMID: 15265316 [PubMed - indexed for MEDLINE]